Literature DB >> 17900863

Effects of RACK1 on cell migration and IGF-I signalling in cardiomyoctes are not dependent on an association with the IGF-IR.

Helen C O'Donovan1, Patrick A Kiely, Rosemary O'Connor.   

Abstract

RACK1 can act as a scaffolding protein to integrate IGF-IR and integrin signalling in transformed cells but its actions in regulating IGF-IR signalling in non-transformed cells are less well understood. Here, we investigated the function of RACK1 in the non-transformed cardiomyocyte cell line H9c2. Overexpression of RACK1 in H9c2 cells was sufficient to increase cell size, increase adhesion to collagen 1, enhance protection from hydrogen peroxide-induced cell death, and increase cell migration. However, cell proliferation was decreased in these cells. Small interfering RNA (siRNA)-mediated suppression of RACK1 in H9c2 cells resulted in decreased cell adhesion and migration, but had no effect on cell proliferation or size. Increased basal and IGF-I-mediated Erk phosphorylation was observed in RACK1-overexpressing H9c2 cells. Interestingly, contrary to observations in transformed cells, RACK1 was not observed to interact with the IGF-IR in H9c2 cells. Also in contrast to observations in transformed cells, IGF-I promoted recruitment of Src to RACK1 as well as recruitment of PKCalpha, and PKCepsilon to RACK1. Overall, the data indicate that in H9c2 cells RACK1 can influence cell size, cell survival, adhesion, migration, but its responses to IGF-I are independent of an association with the IGF-IR. Thus, the composition of the RACK1 scaffolding complex and its effects on IGF-I signalling may be different in transformed and non-transformed cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17900863     DOI: 10.1016/j.cellsig.2007.08.010

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  7 in total

1.  Receptor for activated C kinase 1 (RACK1): a regulator for migration and invasion in oral squamous cell carcinoma cells.

Authors:  Jing Li; Yu Guo; Xiaodong Feng; Zhiyong Wang; Yun Wang; Peng Deng; Dunfang Zhang; Ruinan Wang; Liang Xie; Xiaoping Xu; Yu Zhou; Ning Ji; Jing Hu; Min Zhou; Ga Liao; Ning Geng; Lu Jiang; Zhi Wang; Qianming Chen
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-30       Impact factor: 4.553

2.  RACK1 plays a critical role in mast cell secretion and Ca2+ mobilization by modulating F-actin dynamics.

Authors:  Edismauro G Freitas Filho; Elaine Z M da Silva; Hwei Ling Ong; William D Swaim; Indu S Ambudkar; Constance Oliver; Maria Célia Jamur
Journal:  J Cell Sci       Date:  2021-05-13       Impact factor: 5.285

Review 3.  The insulin-like growth factor (IGF) receptor type 1 (IGF1R) as an essential component of the signalling network regulating neurogenesis.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2009-08-29       Impact factor: 5.590

4.  Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advances.

Authors:  Kenneth Siddle
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-28       Impact factor: 5.555

Review 5.  Targeting Protein Kinase C Downstream of Growth Factor and Adhesion Signalling.

Authors:  Catríona M Dowling; Patrick A Kiely
Journal:  Cancers (Basel)       Date:  2015-07-15       Impact factor: 6.639

6.  Overexpression of RACK1 Promotes Metastasis by Enhancing Epithelial-Mesenchymal Transition and Predicts Poor Prognosis in Human Glioma.

Authors:  Qiao-Li Lv; Yuan-Tao Huang; Gui-Hua Wang; Yan-Ling Liu; Jin Huang; Qiang Qu; Bao Sun; Lei Hu; Lin Cheng; Shu-Hui Chen; Hong-Hao Zhou
Journal:  Int J Environ Res Public Health       Date:  2016-10-18       Impact factor: 3.390

Review 7.  Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation.

Authors:  Leonard Girnita; Claire Worrall; Shin-Ichiro Takahashi; Stefan Seregard; Ada Girnita
Journal:  Cell Mol Life Sci       Date:  2013-11-26       Impact factor: 9.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.